wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q54123254-8FFC7161-5F63-49AA-89A0-1F6C722858EE
Q54123254-8FFC7161-5F63-49AA-89A0-1F6C722858EE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54123254-8FFC7161-5F63-49AA-89A0-1F6C722858EE
Baricitinib for Previously Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
P2860
Q54123254-8FFC7161-5F63-49AA-89A0-1F6C722858EE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54123254-8FFC7161-5F63-49AA-89A0-1F6C722858EE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
978acd15f1a231d52333059c112526b04a0d6846
P2860
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.